## ADMA: ADMA Biologics Inc - XLV: Healthcare

### Executive Summary

PARABOLIC warning: MRS_10 at 8.0% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($17.86)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Dynamic Technology Lab Private Ltd Buys New Shares in ADMA Biologics Inc $ADMA**
- Source: MarketBeat | 20251201T051007 | Somewhat-Bullish | Relevance: 98%
-  Dynamic Technology Lab Private Ltd acquired 15,920 shares of ADMA Biologics Inc, valued at approximately $290,000, during the second quarter, increasing institutional ownership to 75.68%. Despite a downgrade from Weiss Ratings, MarketBeat maintains a "Buy" consensus with a $28.50 price target, following a strong earnings report where ADMA Biologics exceeded revenue estimates and met EPS expectations. The company also demonstrates strong profitability with a 41.01% return on equity and a 44.06% net margin.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.08M) |
| Sells | 2 ($0.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 15.0% (-2.3%)
- Vanguard Group Inc: 8.8% (-1.8%)
- State Street Corpora: 5.7% (+12.3%)
- Invesco Ltd.: 5.2% (-2.4%)
- Sachem Head Capital : 3.8% (+100.0%)

### Key Risks

1. Elevated short interest (9.6%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.40 suggests fair value with growth premium. Forward P/E 20.2x attractive for 61% earnings growth. Quality metrics strong (ROE 63%, ROA 22%, margin 43%). Balance sheet: strong liquidity (7.1x), low leverage (D/E 0.32). Revenue growth strong at 24% YoY. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.8B |
| Beta | 0.43 |
| 52W Range | $13.50 - $25.67 |
| Short Interest | 9.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.40 |
| Forward P/E | 20.2 |
| Current P/E | 32.6 |
| YoY Growth | 61.3% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 12.0% to 8.0% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Extended beyond STRENGTH zone (8.0% > 6.0%), caution on chasing. MRS_5 at 1.2% confirms short-term momentum alignment. Outperforming sector by 6.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 75, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 7.98% (CS: 98) | Strong |
| RSI_14 | 74.6 | Overbought |
| MACD Histogram | 0.41 | Bullish |
| vs SMA20 | 1.181x | Above |
| vs SMA50 | 1.245x | Above |
| vs SMA200 | 1.082x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $19.38
- **Stop Loss:** $17.86 (7.8% risk)
- **Target:** $20.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 493
- **Position Value:** $9,554.34
- **Portfolio %:** 9.55%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

### Earnings

**Next:** 2026-03-02 (Est: $0.20)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.15 | $0.16 | +2.6% |
| 2025Q2 | $0.14 | $0.14 | +7.4% |
| 2025Q1 | $0.17 | $0.11 | -33.3% |
| 2024Q4 | $0.15 | $0.14 | -9.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*